Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: Effects on Activities of Daily LivingOLIN, Jason T; AARSLAND, Dag; XIANGYI MENG et al.Dementia and geriatric cognitive disorders. 2010, Vol 29, Num 6, pp 510-515, issn 1420-8008, 6 p.Article

Activities of daily living in moderate-to-severe alzheimer disease : An analysis of the treatment effects of memantine in patients receiving stable donepezil treatmentFELDMAN, Howard H; SCHMITT, Frederick A; OLIN, Jason T et al.Alzheimer disease and associated disorders. 2006, Vol 20, Num 4, pp 263-268, issn 0893-0341, 6 p.Article

Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analysesALVA, Gustavo; GROSSBERG, George T; SCHMITT, Frederick A et al.International journal of geriatric psychiatry. 2011, Vol 26, Num 4, pp 356-363, issn 0885-6230, 8 p.Article

Effects of Rivastigmine Transdermal Patch and Capsule on Aspects of Clinical Global Impression of Change in Alzheimer's Disease: A Retrospective AnalysisCUMMINGS, Jeffrey L; FERRIS, Steven H; FARLOW, Martin R et al.Dementia and geriatric cognitive disorders. 2010, Vol 29, Num 5, pp 406-412, issn 1420-8008, 7 p.Article

Proxy and surrogate consent in geriatric neuropsychiatric research: Update and recommendationsKIM, Scott Y. H; APPELBAUM, Paul S; JESTE, Dilip V et al.The American journal of psychiatry. 2004, Vol 161, Num 5, pp 797-806, issn 0002-953X, 10 p.Article

Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease DementiaSCHMITT, Frederick A; FARLOW, Martin R; XIANGYI MENG et al.CNS neuroscience & therapeutics (Print). 2010, Vol 16, Num 6, pp 330-336, issn 1755-5930, 7 p.Article

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)OLIN, Jason T; BHATNAGAR, Vinod; REYES, Patricio et al.International journal of geriatric psychiatry. 2010, Vol 25, Num 4, pp 419-426, issn 0885-6230, 8 p.Article

Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease : challenges for the futureFAISON, Warachal E; SCHULTZ, Susan K; OLIN, Jason T et al.International psychogeriatrics. 2007, Vol 19, Num 3, pp 539-558, issn 1041-6102, 20 p.Article

Increasing ethnic minority participation in Alzheimer disease researchOLIN, Jason T; DAGERMAN, Karen S; FOX, Lauren S et al.Alzheimer disease and associated disorders. 2002, Vol 16, pp S82-S85, issn 0893-0341, SUP2Article

Cognitive response to memantine in moderate to severe alzheimer disease patients already receiving donepezil : An exploratory reanalysisSCHMITT, Frederick A; VAN DYCK, Christopher H; WICHEMS, Christine H et al.Alzheimer disease and associated disorders. 2006, Vol 20, Num 4, pp 255-262, issn 0893-0341, 8 p.Article

Depression and bipolar support alliance Consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late lifeCHARNEY, Dennis S; REYNOLDS, Charles F; BORSON, Soo et al.Archives of general psychiatry. 2003, Vol 60, Num 7, pp 664-672, issn 0003-990X, 9 p.Article

Assessment of late life depressionALEXOPOULOS, George S; BORSON, Soo; CUTHBERT, Bruce N et al.Biological psychiatry (1969). 2002, Vol 52, Num 3, pp 164-174, issn 0006-3223, 11 p.Article